Skip to main content
    • Aa
    • Aa

The molecular and cellular defects underlying Pelizaeus–Merzbacher disease

  • Karen J. Woodward (a1)

Pelizaeus–Merzbacher disease (PMD) is a recessive X-linked dysmyelinating disorder of the central nervous system (CNS). The most frequent cause of PMD is a genomic duplication of chromosome Xq22 including the region encoding the dosage-sensitive proteolipid protein 1 (PLP1) gene. The PLP1 duplications are heterogeneous in size, unlike duplications causing many other genomic disorders, and arise by a distinct molecular mechanism. Other causes of PMD include PLP1 deletions, triplications and point mutations. Mutations in the PLP1 gene can also give rise to spastic paraplegia type 2 (SPG2), an allelic form of the disease. Thus, there is a spectrum of CNS disorder from mild SPG2 to severe connatal PMD. PLP1 encodes a major protein in CNS myelin and is abundantly expressed in oligodendrocytes, the myelinating cells of the CNS. Significant advances in our understanding of PMD have been achieved by investigating mutant PLP1 in PMD patients, animal models and in vitro studies. How the different PLP1 mutations and dosage effects give rise to PMD is being revealed. Interestingly, the underlying causes of pathogenesis are distinct for each of the different genetic abnormalities. This article reviews the genetics of PMD and summarises the current knowledge of causative molecular and cellular mechanisms.

Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1P. Heim (1997) Leukodystrophy incidence in Germany. Am J Med Genet 71, 475-478

2F. Pelizaeus (1885) Über eine eigenthümliche Form Spastischer Lähmung mit Cerebralerschinungen auf hereditärer Grundlage (Multiple Sklerose). Arch Psychiatr Nervenkr 16, 698-710

3L. Merzbacher (1910) Eine eigenarige familiär-hereditare Erkrankungsform (Aplasia axialis extra-corticalis congenita). Z ges Neurol Psych 3, 1-138

4A. Dautigny (1986) The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice. Nature 321, 867-869

5K.A. Nave (1986) Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc Natl Acad Sci U S A 83, 9264-9268

6L.D. Hudson (1987) Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc Natl Acad Sci U S A. 84, 1454-1458

8M.G. Mattei (1986) The gene encoding for the major brain proteolipid (PLP1) maps on the q-22 band of the human X chromosome. Hum Genet 72, 352-353

9L.D. Hudson (1989) Mutation of the proteolipid protein gene PLP1 in a human X chromosome-linked myelin disorder. Proc Natl Acad Sci U S A 86, 8128-8131

11J.A. Trofatter (1989) Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. Proc Natl Acad Sci U S A 86, 9427-9430

12P. Saugier-Veber (1994) X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6, 257-262

14J.R. Lupski and C.A. Garcia (1992) Molecular genetics and neuropathology of Charcot-Marie-Tooth disease type 1A. Brain Pathol 2, 337-349

15D. Ellis and S. Malcolm (1994) Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nat.Genet 6, 333-334

16E.A. Sistermans (1998) Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology 50, 1749-1754

18P.J. Wang (1997) Duplication of proteolipid protein gene: a possible major cause of Pelizaeus-Merzbacher disease. Pediatr Neurol 17, 125-128

20K. Inoue (2002) Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 71, 838-853

22I. Griffiths (1998) Current concepts of PLP1 and its role in the nervous system. Microsc Res Tech 41, 344-358

23D.A. Yool (2000) The proteolipid protein gene and myelin disorders in man and animal models. Hum Mol Genet 9, 987-992

24C. Readhead (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12, 583-595

25T. Kagawa (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13, 427-442

26Y. Inoue (1996) Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neurosci Res 25, 161-172

27D. Boison and W. Stoffel (1994) Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci USA 91, 11709-11713

31F. Seitelberger (1995) Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol 5, 267-273

32F. Cailloux (2000) Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Eur J Hum Genet 8, 837-845

33J. Boulloche and J. Aicardi (1986) Pelizaeus-Merzbacher disease: clinical and nosological study. J Child Neurol 1, 233-239

34M.E. Hodes , V.M. Pratt , S.R. Dlouhy (1993) Genetics of Pelizaeus-Merzbacher disease. Dev Neurosci 15, 383-394

35K. Inoue (2005) PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6, 1-16

36J.Y. Garbern (2007) Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis. Cell Mol Life Sci 64, 50-65

37I.E. Scheffer (1991) Pelizaeus-Merzbacher disease: classical or connatal? Neuropediatrics 22, 71-78

38H.J. Diehl (1986) Individual exons encode the integral membrane domains of human myelin proteolipid protein. Proc Natl Acad Sci USA 83, 9807-9811

39K.A. Nave (1987) Splice site selection in the proteolipid protein (PLP1) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci USA 84, 5665-5669

42J.L. Popot , D. Pham Dinh and A. Dautigny (1991) Major Myelin proteolipid: the 4-alpha-helix topology. J Membr Biol 120, 233-246

43T. Weimbs and W. Stoffel (1992) Proteolipid protein (PLP1) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP1. Biochemistry 31, 12289-12296

45R.J. Milner (1985) Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 42, 931-939

46A.T. Campagnoni and R.P. Skoff (2001) The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP1 genes. Brain Pathol 11, 74-91

47C.W. Campagnoni (1992) DM20 mRNA splice product of the myelin proteolipid protein gene is expressed in the murine heart. J Neurosci Res 33, 148-155

48T.M. Pribyl The major myelin protein genes are expressed in the human thymus. J Neurosci Res 45, 812-819

49J.L. Nussbaum and G. Roussel (1983) Immunocytochemical demonstration of the transport of myelin proteolipids through the Golgi apparatus. Cell Tissue Res 234, 547-559

50M. Simons (2000) Assembly of myelin by association of proteolipid protein with cholesterol and galactosylceramide-rich membrane domains. J Cell Biol 151, 143-154

51M. Simons (2002) Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 157, 327-336

52M. Klugmann (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18, 59-70

53O.A. Bizzozero (2001) Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath. J Neurochem 76, 1129-1141

54P.E. Knapp (1996) Proteolipid protein: is it more than just a structural component of myelin? Dev Neurosci 18, 297-308

55K. Kitagawa (1993) A proteolipid protein gene family: expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide. Neuron 11, 433-448

57O. Spörkel (2002) Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development. Glia 37, 19-30

58K. Woodward (1998) Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH. Am J Hum Genet 63, 207-217

59K. Inoue (1999) Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations. Ann Neurol 45, 624-632

60K.J. Woodward (2005) Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination. Am J Hum Genet 77, 966-987

61C. Mimault (1999) Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. Am J Hum Genet 65, 360-369

62N.I. Wolf (2005) Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain 128, 743-751

63M.E. Hodes (2000) Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome. Am J Hum Genet 67, 14-22

65J.R. Lupski (1998) Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 14, 417-422

66K. Inoue and J.R. Lupski (2002) Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet 3, 199-242

67J.A. Lee (2006) Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease. Hum Mol Genet 15, 2250-2265

68J.A. Lee , C.M. Carvalho and J.R. Lupski (2007) A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131, 1235-1247

69C.J. Shaw and J.R. Lupski (2004) Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 13, 57-64

70S. Regis (2001) Prenatal diagnosis of Pelizaeus-Merzbacher disease: detection of proteolipid protein gene duplication by quantitative fluorescent multiplex PCR. Prenat Diagn 21, 668-671

71C.A. Hübner (2005) Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease. Hum Mutat 25, 321-322

72Q. Gao (2005) Genetic diagnosis of PLP1 gene duplications/deletions in patients with Pelizaeus-Merzbacher disease. Clin Genet 68, 466-467

73E. Mikesová (2006) Quantitative multiplex real-time PCR for detection of PLP1 gene duplications in Pelizaeus-Merzbacher patients. Genet Test 10, 215-220

74I. Warshawsky (2006) Multiplex ligation-dependent probe amplification for rapid detection of proteolipid protein 1 gene duplications and deletions in affected males and carrier females with Pelizaeus-Merzbacher disease. Clin Chem 52, 1267-1275

75K. Woodward (1999) Prenatal diagnosis by FISH in a family with Pelizaeus-Merzbacher disease caused by duplication of PLP1 gene. Prenat Diagn 19, 266-268

76J.A. Lee (2005) Prenatal diagnosis of PLP1 copy number by array comparative genomic hybridization. Prenat Diagn 25, 1188-1191

77Y. Verlinsky (2006) Preimplantation genetic diagnosis for Pelizaeus-Merzbacher disease with testing for age-related aneuploidies. Reprod Biomed Online 12, 83-88

78E.A. Sistermans (1996) A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family. Hum Genet 97, 337-339

79J.Y. Garbern (1997) Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19, 205-218

80J.Y. Garbern (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125, 551-561

81G.M. Hobson (2000) Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease. Neurology 55, 1089-1096

82G.M. Hobson (2006) Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes. Hum Mutat 27, 69-77

85A. Dobretsova , N.A. Kokorina and P.A. Wight (2004) Potentiation of myelin proteolipid protein (PLP1) gene expression is mediated through AP-1-like binding sites. J Neurochem 90, 1500-1510

87N. Muncke (2004) Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptoms. J Med Genet 41, e121

88J.A. Lee (2006) Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol 59, 398-403

89B. Uhlenberg (2004) Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 75, 251-260

90N.I. Wolf (2007) Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics 8, 39-44

91M. Bugiani (2006) GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 67, 273-279

92L. Salviati (2007) A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease. Neurogenetics 8, 57-60

93J.L. Orthmann-Murphy (2007) Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci 34, 629-641

97K.A. Nave and O. Boespflug-Tanguy (1996) X-linked developmental defects of myelination: from mouse mutants to human genetic diseases. Neuroscientist 2, 33-43

98K. Inoue (2004) Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 36, 361-369

99K. Al-Saktawi (2003) Genetic background determines phenotypic severity of the PLP1 rumpshaker mutation. J Neurosci Res 72, 12-24

100A.M. Schneider (1992) Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358, 758-761

101T.J. Anderson (1998) Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 394, 506-519

102S.A. Karim (2007) PLP1 overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease. Glia 55, 341-351

103M. Sereda (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16, 1049-1060

104I. Griffiths (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280, 1610-1613

105J.Y. Garbern (1999) Peripheral neuropathy caused by proteolipid protein gene mutations. Ann N Y Acad Sci 883, 351-365

106G. Roussel (2003) Arrest of proteolipid transport through the Golgi apparatus in Jimpy brain. J Neurocytol 16, 195-204

107A. Gow , V.-L.J. Friedrich and R.A. Lazzarini (1994) Intracellular transport and sorting of the oligodendrocyte transmembrane proteolipid protein. J Neurosci Res 37, 563-573

108A. Gow and R.A. Lazzarini (1996) A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet 13, 422-428

109C.E. Thomson (1997) Phenotypic severity of murine PLP1 mutants reflects in vivo and in vitro variations in transport of PLP1 isoproteins. Glia 20, 322-332

110A. Gow , C.M. Southwood and R.A. Lazzarini (1998) Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140, 925-934

111M. Cerghet (2001) Differential expression of apoptotic markers in jimpy and in PLP1 overexpressors: evidence for different apoptotic pathways. J Neurocytol 30, 841-855

112C.M. Southwood (2002) The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36, 585-596

113A.M. Schneider (1995) Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc Natl Acad Sci U S A 92, 4447-4451

114J.P. Taylor (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991-1995

115J.J. Hoozemans (2005) The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol 110, 165-172

116J.J. Hoozemans (2007) Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun 354, 707-711

117E.M. Krämer-Albers (2007) Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia. J Neurosci 26, 11743-11752

118M. McLaughlin (2006) Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation. Glia 53, 715-722

119M. McLaughlin (2007) Genetic background influences UPR but not PLP1 processing in the rumpshaker model of PMD/SPG2. Neurochem Res 32, 167-176

120E. Swanton (2005) Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum. Proc Natl Acad Sci U S A 102, 4342-4347

121A.S. Dhaunchak and K.A. Nave (2007) A common mechanism of PLP1/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc Natl Acad Sci USA 104, 17813-17818

122C. Southwood (2007) Novel alternatively spliced endoplasmic reticulum retention signal in the cytoplasmic loop of Proteolipid Protein-1. J Neurosci Res 85, 471-478

123M.A. Nance (1996) Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease. Neurology 47, 1333-1335

124M.E. Hodes (1997) Nonsense mutation in exon 3 of the proteolipid protein gene (PLP1) in a family with an unusual form of Pelizaeus-Merzbacher disease. Am J Med Genet 69, 121-125

125K. Sivakumar (1999) Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members. Ann Neurol 45, 680-683

126S. Hurst (2006) Quantifying the carrier female phenotype in Pelizaeus-Merzbacher disease. Genet Med 8, 371-378

127M.L. Fanarraga (1991) Rumpshaker: an X-linked mutation affecting CNS myelination. A study of the female heterozygote. Neuropathol Appl Neurobiol 17, 323-334

128K. Woodward (2000) X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations. Eur J Hum Genet 8, 449-454

129K. Inoue (2001) Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement. Ann Neurol 50, 747-754

131I.D. Duncan , W.E. Grever and S.C. Zhang (1997) Repair of myelin disease: strategies and progress in animal models. Mol Med Today 3, 554-561

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *